Related Experiment Video
Updated: Jun 17, 2026
10:46
Using Enzyme-based Biosensors to Measure Tonic and Phasic Glutamate in Alzheimer's Mouse Models
Published on: May 3, 2017
Region-specific alteration in brain glutamate: possible relationship to risk-taking behavior
Bernadette M Cortese1, Todd R Mitchell, Matthew P Galloway
1Department of Psychiatry & Behavioral Sciences, Medical University of South Carolina, Charleston, SC 29425, USA.
Physiology & Behavior
|December 17, 2009
Summary
Total sleep deprivation in rats increased risk-taking behaviors and altered brain glutamate levels. These findings suggest a link between sleep loss, glutamate, and anxiety-related behaviors, potentially impacting conditions like PTSD.
Area of Science:
- Neuroscience
- Behavioral Neuroscience
- Sleep Science
Background:
- Risk-taking behaviors are associated with reduced anxiety and increased motor activity.
- Total sleep deprivation (TSD) in animals mimics these behavioral changes.
- Glutamate, a key neurotransmitter, plays a role in regulating mood and behavior.
Purpose of the Study:
- To investigate the effects of TSD on risk-taking behaviors in rats.
- To examine region-specific changes in brain glutamate levels following TSD.
- To explore the relationship between brain glutamate and TSD-induced behavioral alterations.
Main Methods:
- Rats underwent TSD or were used as controls.
- Behavioral analysis using the elevated plus maze (EPM) to assess fear and risk-taking.
- Measurement of glutamate levels in specific brain regions (hippocampus, thalamus, medial prefrontal cortex).
Main Results:
- Sleep-deprived rats exhibited significantly reduced fear-like behaviors and increased risk-taking in the EPM.
- TSD led to a significant increase in glutamate levels in the hippocampus and thalamus.
- An inverse relationship was found between medial prefrontal cortex glutamate and risk-taking, while a positive association existed between the hippocampus-to-medial prefrontal cortex glutamate ratio and risk-taking.
Conclusions:
- TSD induces behavioral changes indicative of reduced anxiety and increased risk-taking in rats.
- Alterations in hippocampal and thalamic glutamate levels are associated with TSD.
- Brain glutamate modulation, particularly involving the medial prefrontal cortex and hippocampus, may underlie the relationship between sleep deprivation, anxiety, and risk-taking behaviors.
Related Concept Videos
01:28Human Genetics
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
The complex relationship between genetics and psychology is observable through common biological components such...
01:23Role of Neurotransmitters in Memory
Neurotransmitters are integral to the brain's communication system, enabling neurons to transmit signals across synapses. This chemical exchange underpins various cognitive functions, including memory processes. The role of neurotransmitters in memory is multifaceted, influencing the encoding, consolidation, and retrieval of memories through their action on different neural circuits.
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is critical for...
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is critical for...
01:30Attention-Deficit/Hyperactivity Disorder
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings.